Sign in

CIK 0001661181

  • Accelerated filer

Organogenesis Holdings Inc.

Sign in to watch
Ticker
ORGO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-575-0775
Business address
85 DAN ROAD, CANTON, MA, 02021
Former names
Avista Healthcare Public Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-12-10 Grow Brian Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +958 958
2018-12-10 Grow Brian Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +4,060 4,060
2018-12-10 Grow Brian Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +30,450 30,450
2018-12-10 Grow Brian Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +102,200 102,200
2018-12-10 Grow Brian Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +60,900 60,900
2018-12-10 Freedman Lori VP and General Counsel Grant or award · Stock Option (Right to Buy) +40,600 40,600
2018-12-10 Cunningham Timothy M. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +559,620 559,620
2018-12-10 Bilbo Patrick Chief Operating Officer Grant or award +121,800 121,800
2018-12-10 Bilbo Patrick Chief Operating Officer Grant or award · Stock Option (Right to Buy) +30,450 30,450
2018-12-10 Bilbo Patrick Chief Operating Officer Grant or award · Stock Option (Right to Buy) +152,250 152,250
2018-12-10 Bilbo Patrick Chief Operating Officer Grant or award · Stock Option (Right to Buy) +142,100 142,100
2018-12-10 Bilbo Patrick Chief Operating Officer Grant or award · Stock Option (Right to Buy) +101,500 101,500
2018-12-10 Gillheeney Gary S. President and CEO Grant or award · Stock Option (Right to Buy) +397,900 397,900
2018-12-10 Gillheeney Gary S. President and CEO Grant or award · Stock Option (Right to Buy) +704,410 704,410
2018-12-10 Gillheeney Gary S. President and CEO Grant or award · Stock Option (Right to Buy) +664,804 664,804
2018-12-10 Gillheeney Gary S. President and CEO Grant or award · Stock Option (Right to Buy) +1,637,631 1,637,631
2018-12-10 Avista Acquisition Corp. 10% owner Other disposition · Class B Ordinary Shares −3,247,668 1,048,691
2018-12-10 Bjorklund Hakan Director Returned to the company · Class B Ordinary Shares −243,896 69,571
2018-12-10 MARKISON BRIAN A Director Returned to the company · Class B Ordinary Shares −442,151 133,589
2018-12-10 Harwood Charles C Jr Director Returned to the company · Class B Ordinary Shares −243,896 69,571

Page 30 of 32 · 627 trades